Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
Friday, September 29, 2023Baudax Bio Inc the Company or Baudax Bio NASDAQ BXRX a biotechnology company focused on developing T cell receptor TCR therapies utilizing human regulatory T cells Tregs
BioLineRx Announces Encouraging Data from Pilot Phase of Phase 2 Combination Clinical Trial with Motixafortide in First-Line Pancreatic Cancer (PDAC)
Friday, September 29, 2023BioLineRx Ltd NASDAQ BLRX TASE BLRX a commercial stage biopharmaceutical company pursuing lifechanging therapies in oncology and rare diseases today announced encouraging data from the singlearm pilot phase of the investigatorinitiated CheMoMETPANC P...
Calliditas Therapeutics granted orphan drug designation by the FDA for the treatment of Alport syndrome with setanaxib
Thursday, September 28, 2023Calliditas Therapeutics AB Nasdaq CALT Nasdaq Stockholm CALTX Calliditas today announced that the US Food and Drug Administration FDA has granted orphan drug designation ODD to the company for the treatment of Alport syndrome with setanaxib
Cosmo And Glenmark Announce The Signing Of Distribution And License Agreements For Winlevi® In Europe And South Africa
Thursday, September 28, 2023Cosmo Pharmaceuticals NV SIX COPN XETRA C Cosmo and Glenmark Specialty SA a subsidiary of Glenmark Pharmaceuticals Ltd Glenmark today announced the signing of distribution and license agreements for Winlevi clascoterone cream in Europe and South Afr...
HRH Princess Astrid of Belgium visits Telix's New European Manufacturing Facility in Brussels South
Thursday, September 28, 2023Telix Pharmaceuticals Limited ASX TLX Telix the Company has welcomed Her Royal Highness Princess Astrid Princess of Belgium to Telix Manufacturing Solutions TMS the Companys recently inaugurated production facility in Brussels South Seneffe in the Wa...
Sandoz receives European Commission approval for Tyruko® (natalizumab), first and only biosimilar for multiple sclerosis in Europe
Wednesday, September 27, 2023Sandoz a global leader in generic and biosimilar medicines today announced that the European Commission EC granted marketing authorization for the first and only biosimilar Tyruko natalizumab developed by Polpharma Biologics
Repligen Announces Agreement to Acquire Fluid Management Innovator Metenova
Wednesday, September 27, 2023Repligen Corporation NASDAQRGEN a life sciences company focused on bioprocessing technology leadership today announced that it has entered into a definitive agreement to acquire privatelyheld Metenova AB Metenova of Mlndal Sweden
Biophytis And Skyepharma Sign A Partnership Agreement For The Production Of Sarconeos (Bio101)
Tuesday, September 26, 2023Biophytis and Skyepharma a French pharmaceutical company specializing in the formulation development and production of pharmaceutical products
AbbVie Announces European Commission Approval of TEPKINLY® (epcoritamab) for Adults with Relapsed or Refractory Diffuse Large B-cell Lymphoma
Tuesday, September 26, 2023AbbVie NYSE ABBV today announced that the European Commission EC has granted conditional marketing authorization for TEPKINLY epcoritamab as a monotherapy for the treatment of adult patients
The European Commission approves ORSERDU® (elacestrant) from the Menarini group for the treatment of patients
Monday, September 25, 2023The Menarini Group Menarini a leading international pharmaceutical and diagnostics company and Stemline Therapeutics Inc Stemline a wholly owned subsidiary by the Menarini Group today announced the approval by the European Commission of ORSERDU
